G
CRL icon

GlobalBridge’s Charles River Laboratories CRL Stock Holding History

GlobalBridge’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$266K Sell
4,401
-3,874
-47% -$226K 0.12% 252
2013
Q4 		$439K Buy
8,275
+901
+12% +$45.2K 0.22% 170
2013
Q3 		$341K Buy
7,374
+406
+6% +$18.6K 0.18% 184
2013
Q2 		$286K Buy
+6,968
New +$299K 0.16% 217

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

GlobalBridge's CRL Position: Q1 2014 in Review

GlobalBridge reduced its Charles River Laboratories (CRL) stake by 47% in Q1 2014, selling an estimated $226K and leaving 4,401 shares worth $266K. The position accounts for 0.12% of the portfolio, ranked #252.

GlobalBridge first reported a position in CRL in Q2 2013 and has held it in 4 quarters since. The position peaked at $439K in Q4 2013. 258 funds tracked by Wall St. Rank hold CRL as of Q1 2014.

  • GlobalBridge held 4,401 shares of Charles River Laboratories worth $266K as of Q1 2014.
  • GlobalBridge sold 3,874 Charles River Laboratories shares in Q1 2014, an estimated $226K.
  • Charles River Laboratories made up 0.12% of GlobalBridge's portfolio in Q1 2014, its #252 holding.
  • GlobalBridge first reported a position in Charles River Laboratories in Q2 2013 and has held it in 4 quarters since.
  • GlobalBridge's Charles River Laboratories position peaked at $439K in Q4 2013.
  • 258 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2014.

Based on GlobalBridge's 13F filing for Q1 2014, filed 8 Apr 2014.